Many MindedIndia's Precision-Fermented Protein Deal Targets Food Security
Symbiotec Pharmalabs has signed a 10-year take-or-pay agreement with an unnamed European partner to produce precision-fermented protein at its Ujjain facility in India. The facility includes four 100,000-litre fermentation tanks and modular downstream processing capabilities. A new dedicated plant with hundreds of thousands of litres of fermentation capacity is planned, with expansion options for the European partner to reach millions of litres. Symbiotec has pharmaceutical-grade quality systems and regulatory approvals from the US FDA, Japan's Pharmaceuticals and Medical Devices Agency, the EU, and WHO. The company has operated for over 30 years and serves over 200 customers in more than 40 countries. India's biotech sector targets $691 billion by 2035, up from $195 billion in 2024, under the BioE3 strategy.
This deal leverages Symbiotec's regulatory credibility and existing infrastructure to scale sustainable protein production. The facility's modular design allows for phased expansion, potentially lowering costs for food-insecure populations by increasing supply of affordable protein. The project aligns with India's national bioeconomy target of $2.6 trillion by 2047.
The mechanism moves food security by scaling a production method that could reduce protein costs where traditional agriculture faces climate and land constraints. If the European partner achieves millions of litres of output, it may provide more affordable protein to food-insecure communities in India and beyond. What to watch: The pace of expansion, regulatory compliance for new fermentation scales, and whether the 10-year deal meets the target for food-insecure populations. (Source published in 2026, indicating possible typo)
Source: Green Queen